Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for prevention of postoperative nausea and vomiting in laparoscopic abdominal or gynecologic surgery
CTR20170634Phase 3Completed
- Sponsor
- Helsinn
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of palonosetron in postoperative nausea and vomiting (PONV), sponsored by Helsinn. Started Jul 2017; status: completed.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on CTR20170634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170634.